An inexpensive programmable optogenetic platform for controlled neuronal activation regimens in

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Lensless light guide-coupled LED illumination for low-cost microscopy.HardwareX · 2025
   Article
2. A neuropeptide signal confers ethanol state dependency during olfactory learning inProceedings of the National Academy of Sciences of the United States of America · 2022
   Article
3. Identification of a Hydroxygallic Acid Derivative, Zingibroside R1 and a Sterol Lipid as Potential Active Ingredients ofNutrients · 2022
   Article
4. Low-cost programable stroboscopic illumination with sub-microsecond pulses for high-throughput microfluidic applications.HardwareX · 2022
   Article
5. Possibilities in bioelectronics: Super humans or science fiction?APL bioengineering · 2021
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract